Detalhe da pesquisa
1.
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants.
Mol Ther
; 31(11): 3322-3336, 2023 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37689971